Duke University Study Suggests Gene Patents Don’t Advance Care for Patients

Pathologists already find it difficult to obtain gene patent licenses needed to offer multi-gene molecular diagnostic tests Patents on human genes are a major issue in pathology and clinical laboratory testing. Now a new report based on the study of the positive and negative consequences of gene patenting comes to the conclusion that patents on human genes tend to deter competition in the gene testing market more than they encourage further development of new technologies for measuring the...

Common Gene Abnormalities Found in Many Types of Cancers

Multi-marker pathology cancer tests likely to be developed from this research Pathologists and other clinical laboratory scientists can expect to see a number of multi-biomarker genetic tests for cancer as a result of research that is identifying specific gene abnormalities that are common to certain cancers and promote the growth of these cancers. Variations in these mutations make a difference in the effectiveness of certain treatments. With the aid of recent advances in genomic mapping...

Australian Health Insurer NIB and Navigenics Team Up to Offer Cut-Rate Genetic Testing to NIB Customers

Australian patients are using an American clinical pathology laboratory for their genetic testing needs It’s a half-price sale of genetic clinical laboratory tests for 5,000 customers of Australian health insurer NIB. NIB wants to encourage its beneficiaries to screen themselves to identify their genetic tendencies for such conditions as heart disease, diabetes, some cancers, and other diseases with a known genetic component. NIB has arranged for California-based Navigenics to conduct the...
;